Corticosteroid toxicity in neuro-oncology patients
- 1 June 1987
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 5 (2) , 125-128
- https://doi.org/10.1007/bf02571300
Abstract
Hospital charts from 59 patients with intracranial malignancy or epidural spinal cord compression were reviewed to establish the frequency of clinically important corticosteroid toxicities and to determine treatment or patient characteristics which were predictive for toxicity. Thirty patients (51%) developed at least one steroid toxicity and eleven (19%) required hospital admission for diagnosis and/or management of steroid-related complications. In this retrospective analysis the duration of steroid therapy and the total administered dose predicted for toxicity. Patients with toxicity also had a significant fall in the serum albumin level. Important corticosteroid toxicity occurs frequently in neuro-oncology patients. Further research should be directed at developing non-toxic alternatives to corticosteroids.Keywords
This publication has 11 references indexed in Scilit:
- Treatment outcome and complications in patients treated for malignant epidural spinal cord compression (SCC)Journal of Neuro-Oncology, 1985
- Management of Spinal Epidural MetastasesNeurosurgery, 1983
- Peptic ulcer disease and other complications in patients receiving dexamethasone palliation for brain metastasis.1982
- Epidural spinal cord compression from metastatic tumor: Results with a new treatment protocolAnnals of Neurology, 1980
- Epidural Lipomatosis: A Complication of Corticosteroid TherapyAnnals of Internal Medicine, 1979
- The complications of high‐dose corticosteroid therapy in neurosurgical patients: A prospective studyAnnals of Neurology, 1977
- Acute perforation of the colon associated with chronic corticosteroid therapyThe American Journal of Surgery, 1976
- Dose dependency of Decadron in patients with partially excised brain tumorsJournal of Neurosurgery, 1973
- Acute adverse reactions to prednisone in relation to dosageClinical Pharmacology & Therapeutics, 1972
- PREDNISONE SIDE-EFFECTS AND SERUM-PROTEIN LEVELSThe Lancet, 1971